drug
TENOFOVIR DISOPROXIL FUMARATE
Marketedupdated 5mo agoby Hetero USA Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- tagApproval4 co-mentions · 2 sources
- drugEMTRICITABINE, RILPIVIRINE, AND TENOFOVIR ALAFENAMIDE2 co-mentions · 1 sources
- drugEMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE2 co-mentions · 1 sources
- tagSmall Molecule2 co-mentions · 2 sources
- drugemtricitabine2 co-mentions · 1 sources
- druglamivudine1 co-mentions · 1 sources
- drugEpivir-HBV1 co-mentions · 1 sources
- companyLupin Ltd1 co-mentions · 1 sources
all catalysts(1)
Trials studying TENOFOVIR DISOPROXIL FUMARATE
- phase3Clinical Trial of TQA3605 Tablet in Combination With Nucleos(t)Ide Analogues(NAs) Versus NAs Alone for the Treatment of Patients With Chronic Hepatitis B Virus Infection Who Have Undergone Treatment and Exhibit Low Viral Load or Poor Response
- phase2Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102)
- phase1Drug-Drug Interaction Study Between Hydronidone and Entecavir, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide, and Tenofovir Amibufenamide
- phase2Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN 103)
- —Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
- phase2Trial Evaluating a First Line Combination Therapy With Raltegravir, Emtricitabine and Tenofovir in HIV-2 Infected Patients
- phase4The COMBAT HBV Feasibility Trial
- phase3Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that